HIV And Retroviruses - USMLE Step 1

1. The pathogen responsible for this patient's disseminated disease is most likely which of the following?
   Answer: Mycobacterium avium complex Disseminated Mycobacterium avium complex (MAC) infection is a common opportunistic infection in patients with advanced AIDS, typically occurring when the CD4 count drops below 50 cells/mm³. The clinical presentation of systemic symptoms like fever, night sweats, weight loss, and diarrhea is classic for disseminated MAC. While M. tuberculosis can occur at any CD4 count, it is more common at higher counts than MAC.
2. The viral enzyme most likely targeted by this new agent is which of the following?
   Answer: Protease HIV protease is a viral enzyme essential for the late stages of replication. It cleaves the Gag and Gag-Pol polyproteins into their individual functional components (e.g., p24 capsid, p17 matrix, reverse transcriptase, integrase). Inhibition of protease prevents this maturation step. As a result, immature, non-infectious virions are assembled and released from the cell, effectively stopping the spread of the virus.
3. The conformational change required for the fusion of the HIV envelope with the host cell membrane is mediated by which of the following viral proteins?
   Answer: gp41 HIV entry is a two-step process involving two envelope glycoproteins. First, the surface glycoprotein gp120 binds to the CD4 receptor and a coreceptor (CCR5 or CXCR4). This binding event induces a conformational change that exposes the transmembrane glycoprotein gp41. The newly exposed gp41 protein then inserts into the host cell membrane and refolds, pulling the viral and host membranes together and mediating their fusion. p24 is the capsid protein, and p17 is the matrix protein.
4. The primary function of CD8+ T-lymphocytes in controlling HIV infection is which of the following?
   Answer: Inducing apoptosis in virally infected CD4+ T-cells CD8+ cytotoxic T-lymphocytes (CTLs) are crucial for the cell-mediated immune response against HIV. They recognize viral peptides presented on MHC class I molecules on the surface of infected cells. Upon recognition, CTLs kill the infected cells by releasing perforin and granzymes, which induce apoptosis. This process is a major contributor to controlling viral replication and eliminating virally infected cells.
5. The development of toxoplasmic encephalitis in this patient is primarily due to the loss of which of the following immune functions?
   Answer: Th1-mediated activation of macrophages Control of latent Toxoplasma gondii infection relies heavily on cell-mediated immunity. CD4+ T-helper cells, specifically the Th1 subset, are critical for this process. Th1 cells produce interferon-gamma (IFN-γ), which is the principal cytokine responsible for activating macrophages to kill intracellular tachyzoites. With a CD4 count of 75 cells/mm³, this patient has a profound defect in Th1 function, allowing for the reactivation of latent toxoplasmosis and the development of encephalitis.
6. This interaction occurs because atazanavir inhibits which of the following host systems, leading to increased levels of simvastatin?
   Answer: Cytochrome P450 enzymes Most HIV protease inhibitors, including atazanavir, are potent inhibitors of the cytochrome P450 system, particularly the CYP3A4 isoenzyme. Simvastatin and many other statins are extensively metabolized by CYP3A4. Co-administration of a protease inhibitor with simvastatin can block its metabolism, leading to significantly increased plasma concentrations and a heightened risk of dose-dependent adverse effects like myopathy and rhabdomyolysis.
7. Which of the following is a major mechanism contributing to the depletion of uninfected CD4+ T-cells in chronic HIV infection?
   Answer: Activation-induced cell death (apoptosis) While direct viral killing of infected cells occurs, a major contributor to CD4+ T-cell depletion, especially of uninfected 'bystander' cells, is apoptosis. Chronic immune activation caused by HIV leads to increased expression of pro-apoptotic molecules like Fas (CD95) and Fas-ligand on T-cells. This renders both infected and uninfected activated T-cells highly susceptible to activation-induced cell death, contributing significantly to lymphopenia.
8. This change in viral tropism is most likely due to a mutation in the viral env gene that alters the binding affinity for which of the following host cell surface molecules?
   Answer: CXCR4 HIV tropism is determined by the coreceptor it uses in addition to CD4. Macrophage-tropic (M-tropic or R5) strains use the CCR5 coreceptor, found on macrophages, dendritic cells, and memory T cells. T-cell-tropic (T-tropic or X4) strains use the CXCR4 coreceptor, found primarily on naive T-lymphocytes. A switch from CCR5 to CXCR4 usage (a 'tropism switch') often occurs late in disease and is associated with accelerated CD4+ T-cell depletion and disease progression.
9. Dolutegravir effectively suppresses viral replication by inhibiting the enzyme responsible for which of the following functions?
   Answer: Covalently linking viral DNA to host DNA Dolutegravir is an integrase strand transfer inhibitor (INSTI). The viral enzyme integrase is responsible for inserting the reverse-transcribed viral DNA (provirus) into the host cell's genome by covalently linking it to the host DNA. By inhibiting this enzyme, dolutegravir prevents the establishment of a permanent, latent infection within the host cell, thus halting the replication cycle. Option B describes reverse transcriptase, C describes gp41, and D describes protease.
10. Detection of which of the following viral proteins allows for earlier diagnosis of acute HIV infection compared to antibody-only tests?
    Answer: p24 The p24 protein is the viral capsid protein, a core component of the HIV virion. It is produced in large quantities during the initial burst of viral replication in acute infection. p24 antigen can be detected in the blood as early as 10-14 days post-infection, before the development of detectable anti-HIV antibodies. Fourth-generation assays detect both p24 antigen and HIV antibodies, shortening the diagnostic 'window period' compared to older antibody-only tests.
11. The efficacy of raltegravir is due to its ability to prevent which of the following steps in the HIV replication cycle?
    Answer: Integration of proviral DNA into the host chromosome Raltegravir is an integrase strand transfer inhibitor (INSTI). It binds to and inhibits the viral enzyme integrase, which is responsible for covalently inserting the proviral DNA (synthesized by reverse transcriptase) into the host cell's chromosome. This step is critical for establishing a permanent, latent infection. By blocking integration, raltegravir effectively halts the viral replication cycle.
12. This patient's clinical presentation is most consistent with which of the following stages of HIV infection?
    Answer: Acute retroviral syndrome The patient is presenting with a mononucleosis-like illness approximately 2-4 weeks after a potential exposure. This constellation of symptoms (fever, fatigue, pharyngitis, lymphadenopathy, rash) is characteristic of acute retroviral syndrome. The laboratory findings of a high viral load with a negative antibody test but positive p24 antigen test confirm an acute infection within the 'window period' before antibodies have fully developed. Clinical latency is asymptomatic, and AIDS involves severe immunodeficiency.
13. Based on this opportunistic infection, this patient's CD4+ T-lymphocyte count is most likely below which of the following thresholds?
    Answer: 200 cells/mm³ The presence of an AIDS-defining illness, such as Pneumocystis jirovecii pneumonia (PJP), is sufficient for a diagnosis of AIDS. PJP typically occurs when the CD4+ T-cell count falls below 200 cells/mm³. This level of immunosuppression severely impairs cell-mediated immunity, which is crucial for controlling this opportunistic fungus. Prophylaxis for PJP is recommended for all HIV-infected individuals with a CD4 count below this threshold.
14. The LTRs of the integrated HIV provirus contain regulatory sequences that serve as a binding site for which of the following?
    Answer: Host cell transcription factors The long terminal repeats (LTRs) are created during reverse transcription and are found at both ends of the integrated provirus. The 5' LTR acts as a powerful promoter for viral gene expression. It contains binding sites for host cell transcription factors, such as NF-κB and Sp1, as well as for the viral Tat protein. The activation state of the T-cell influences the availability of these transcription factors, which in turn regulates the transcription of the proviral DNA by the host's RNA polymerase II.
15. Which of the following best explains the finding of polyclonal hypergammaglobulinemia in patients with chronic HIV infection?
    Answer: Chronic, non-specific activation of B-lymphocytes HIV infection leads to a state of profound immune dysregulation that includes polyclonal B-cell activation. Several factors contribute, including direct effects of viral proteins on B-cells, loss of regulatory T-cell function, and chronic immune stimulation. This results in a non-specific, polyclonal activation of B-lymphocytes, leading to hypergammaglobulinemia. Despite the high levels of immunoglobulins, the specific antibody response to new antigens is often impaired, contributing to the overall immunodeficiency.
16. The principle of the initial screening immunoassay (e.g., ELISA) involves the detection of patient antibodies binding to which of the following?
    Answer: Immobilized HIV antigens on a solid-phase support The enzyme-linked immunosorbent assay (ELISA), or the more general term immunoassay, used for HIV screening works by detecting the presence of anti-HIV antibodies (and p24 antigen in 4th-gen tests) in a patient's serum. This is accomplished by using a solid support (like a microtiter plate) coated with specific, purified HIV antigens. If antibodies are present in the patient's serum, they will bind to these immobilized antigens. A secondary, enzyme-linked antibody is then added, which generates a detectable signal.
17. Which of the following processes is directly inhibited by the active form of tenofovir?
    Answer: Synthesis of double-stranded DNA from a viral RNA template Tenofovir is a nucleotide reverse transcriptase inhibitor (NRTI). After phosphorylation to its active form (tenofovir diphosphate), it competes with deoxyadenosine triphosphate for incorporation into the growing DNA chain by the viral reverse transcriptase. Because it lacks a 3'-hydroxyl group, its incorporation results in chain termination, thus inhibiting the synthesis of double-stranded proviral DNA from the viral RNA template.
18. The toxicity observed in this patient is related to the off-target inhibition of which of the following host enzymes by emtricitabine?
    Answer: DNA polymerase gamma Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI). The primary mechanism of toxicity for the NRTI class is the inhibition of mitochondrial DNA polymerase gamma. This host enzyme is responsible for replicating mitochondrial DNA. Inhibition leads to mitochondrial dysfunction, impaired oxidative phosphorylation, and consequent adverse effects such as lactic acidosis, pancreatitis, and peripheral neuropathy.
19. The Tat protein enhances viral production by performing which of the following functions?
    Answer: Acting as a transcriptional activator to increase elongation of viral transcripts Tat stands for 'Trans-Activator of Transcription.' It is a regulatory protein that binds to a specific RNA sequence called the TAR (trans-activation response) element, located at the 5' end of all viral transcripts. This binding significantly increases the processivity of the host RNA polymerase II, preventing premature termination and promoting the synthesis of full-length viral mRNAs. This creates a powerful positive feedback loop, leading to a massive amplification of viral gene expression.
20. Mutations in the gene encoding which of the following proteins are most responsible for HIV's ability to evade the neutralizing antibody response?
    Answer: env The env gene encodes the envelope glycoproteins gp120 and gp41, which are displayed on the surface of the virion and are the primary targets for neutralizing antibodies. The viral reverse transcriptase is highly error-prone, leading to a high mutation rate. Mutations in the env gene are particularly significant because they alter the structure of gp120, allowing the virus to escape recognition by pre-existing antibodies. This constant evolution is a major obstacle to vaccine development.

Start this quiz